Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. B. van Etten

Publications

Comment on the RAPIDO Trial Point-Counterpoint Debate

Less pneumonia after nCRT and resection in oesophageal cancer using proton RT

Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review

Referral patterns of GIST patients: data from a nationwide study

Ultrasound-guided quantitative fluorescence molecular endoscopy for monitoring response in patients with esophageal cancer following neoadjuvant chemoradiotherapy

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer

Authors' reply - A sensitivity analysis of the RAPIDO clinical trial

Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer?: No, it does not

Corrigendum to “Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not”: [ESMO Open 8 (2023) 101645]

Read more

Press/media

Nieuwe behandeling van endeldarmkanker leidt tot minder uitzaaiingen